According to Hanyu Pharmaceutical, recently, Hanyu Pharmaceutical and Shenzhen Carbon Cloud Zhi Peptide Pharmaceutical Technology Co., Ltd. officially reached a strategic investment cooperation. According to the agreement, Hanyu Pharmaceutical will use 10 million yuan in cash to purchase additional registered capital for Carbon Cloud Zhi Peptide. After the capital increase is completed, it will hold 0.6623% of its shares, marking a stage of deep cooperation between the two sides from early R&D collaboration to capital binding and industrial collaboration.

According to Hanyu Pharmaceutical, recently, Hanyu Pharmaceutical and Shenzhen Carbon Cloud Zhi Peptide Pharmaceutical Technology Co., Ltd. officially reached a strategic investment cooperation. According to the agreement, Hanyu Pharmaceutical will use 10 million yuan in cash to purchase additional registered capital for Carbon Cloud Zhi Peptide. After the capital increase is completed, it will hold 0.6623% of its shares, marking a stage of deep cooperation between the two sides from early R&D collaboration to capital binding and industrial collaboration.